JP Morgan Chase’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $309M | Buy |
|
|||||
|
2022
Q2 | $128M | Sell |
|
|||||
|
2022
Q1 | $162M | Sell |
|
|||||
|
2021
Q4 | $192M | Sell |
|
|||||
|
2021
Q3 | $203M | Sell |
|
|||||
|
2021
Q2 | $170M | Sell |
|
|||||
|
2021
Q1 | $120M | Buy |
|
|||||
|
2020
Q4 | $144M | Buy |
|
|||||
|
2020
Q3 | $105M | Buy |
|
|||||
|
2020
Q2 | $118M | Buy |
|
|||||
|
2020
Q1 | $52.3M | Buy |
|
|||||
|
2019
Q4 | $78.1M | Sell |
|
|||||
|
2019
Q3 | $64M | Sell |
|
|||||
|
2019
Q2 | $65.8M | Sell |
|
|||||
|
2019
Q1 | $91.1M | Sell |
|
|||||
|
2018
Q4 | $70.1M | Buy |
|
|||||
|
2018
Q3 | $57.5M | Buy |
|
|||||
|
2018
Q2 | $56.4M | Buy |
|
|||||
|
2018
Q1 | $23.6M | Sell |
|
|||||
|
2017
Q4 | $24.8M | Buy |
|
|||||
|
2017
Q3 | $18.2M | Sell |
|
|||||
|
2017
Q2 | $14.8M | Buy |
|